HCID 6481592, compound → HCID 67053684, compound
Reaction equation
C(O[C:4](=[O:34])[CH2:5][CH2:6][N:7]1[CH2:12][CH2:11][CH:10]([NH:13][C:14]2[N:18]([CH2:19][C:20]3[C:25]([OH:26])=[CH:24][CH:23]=[C:22]([CH3:27])[N:21]=3)[C:17]3[CH:28]=[C:29]([CH3:33])[CH:30]=[C:31]([CH3:32])[C:16]=3[N:15]=2)[CH2:9][CH2:8]1)C.CO.[NH3:37]>>[OH:26][C:25]1[C:20]([CH2:19][N:18]2[C:17]3[CH:28]=[C:29]([CH3:33])[CH:30]=[C:31]([CH3:32])[C:16]=3[N:15]=[C:14]2[NH:13][CH:10]2[CH2:9][CH2:8][N:7]([CH2:6][CH2:5][C:4]([NH2:37])=[O:34])[CH2:12][CH2:11]2)=[N:21][C:22]([CH3:27])=[CH:23][CH:24]=1Participants
Conditions
- Temperature
- 70 °C
Procedure
A mixture of 3-{4-[1-(3-Hydroxy-6-methyl-pyridin-2-ylmethyl)-4,6-dimethyl-1H-benzoimidazol-2-ylamino]-piperidin-1-yl}-propionic acid ethyl ester (0.0065 mol) in methanol/NH3 7N (15 ml) was stirred in a sealed vessel at 70° C. for 12 hours. The solvent was evaporated until dryness. The residue (0.3 g) was purified by column chromatography over silica gel (eluent: CH2Cl2/CH3OH/NH4OH 85/14/1; 5 μm). The pure fractions were collected and the solvent was evaporated. The residue (0.09 g, 32%) was crystallized from diisopropylether. The precipitate was filtered off and dried, yielding 0.086 g of 3-{4-[1-(3-hydroxy-6-methyl-pyridin-2-ylmethyl)-4,6-dimethyl-1H-benzoimidazol-2-ylamino]-piperidin-1-yl}-propionamide (compound 5, 30%, melting point: 212° C.).
Workup
- customThe solvent was evaporated until dryness
- customThe residue (0.3 g) was purified by column chromatography over silica gel (eluent: CH2Cl2/CH3OH/NH4OH 85/14/1; 5 μm)
- customThe pure fractions were collected
- customthe solvent was evaporated
- customThe residue (0.09 g, 32%) was crystallized from diisopropylether
- filtrationThe precipitate was filtered off
- customdried
Sources & evidence
- ORD record
- ord-c6ed8a493363455fb529b56d3e655cc1
- Source dataset
- uspto-grants-2008_04
- Patent number
- US07355051B2
Reaction notes
Loading…